Ranitidine 300 mg recalled over manufacturing violations
- Recall date
- January 15, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Direct Rx recalls Ranitidine 300 mg, 30 Tabs bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 NDC 61919-455…
- Recall number
- D-0017-2021
- FDA classification
- Class II
- Brand / firm
- Direct Rx
- Sold / distributed
- FL, GA
Why it was recalled
CGMP Deviations: Presence of NDMA impurity detected in product.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Ranitidine 300 mg, 30 Tabs bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 NDC 61919-455-30
Get recall alerts
Free email alert whenever Direct Rx has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Direct Rx